Legal status by country
Is Cebranopadol legal?
Written by Aaron CuhaReviewed Sep 2026
How Cebranopadol is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Investigational, not approved | Investigational, not licensed | Investigational, not registered | Investigational, not approved |
| Note | A mu-opioid agonist; would be a controlled substance if approved. | None recorded | None recorded | None recorded |
US FDA status: Not FDA approved. Two phase 3 acute pain trials completed 2024 to 2025 with no posted results; chronic cancer pain phase 3 terminated for low accrual. No application in openFDA as of September 2026.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.